Melatonin use in managing insomnia in children with autism and other neurogenetic disorders - An assessment by the international pediatric sleep association (IPSA).
Suresh Kotagal,
Beth Malow,
Karen Spruyt,
Guanghai Wang,
Carlos Ernest Bolaños Almeida
et al.
Other
Sleep medicine
2024
24 인용
연구 설계
- 연구 유형
- narrative review / clinical guidance
- 대상 집단
- Children with autism spectrum disorder and other neurogenetic disorders with insomnia
- 중재
- Melatonin use in managing insomnia in children with autism and other neurogenetic disorders - An assessment by the international pediatric sleep association (IPSA). varies
- 대조군
- placebo or standard care
- 일차 결과
- sleep onset, sleep quality in autism/neurogenetic disorder children
- 효과 방향
- Positive
- 비뚤림 위험
- Unclear
초록
Though it is widely prescribed for improving sleep of children with autism and other neurogenetic disorders, there is a need for practical guidance to clinicians on the use of melatonin for managing insomnia in this population. Because data were either lacking or inconclusive, a task force was established by the International Pediatric Sleep Association (IPSA) to examine the literature based on clinical trials from 2012 onwards. A summary of evidence pertaining to melatonin's utility and potential side effects, practice-related caveats, and insights for use are published herewith.
요약
A summary of evidence pertaining to melatonin's utility and potential side effects, practice-related caveats, and insights for use are published herewith.